![](https://news.unchealthcare.org/wp-content/uploads/sites/1159/2022/12/CAR-T-GBM_FINAL3C-1-600x440.jpg)
December 8, 2022
Phase I Clinical Trial Using CAR-T for Glioblastoma to Begin at UNC Medical Center
UNC Health is leading the way in glioblastoma treatment with a new clinical trial. The study will evaluate the safety and tolerability of CAR-T immunotherapy in patients with recurrent or progressive glioblastoma.